IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 80
Titolo Data di pubblicazione Autore(i) File
Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy? 1-gen-2014 Plotti, F; Zullo, Ma; Guzzo, F; Montera, R; Angioli, R
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 1-gen-2015 Angioli, R; Plotti, F; Aloisi, A; Scaletta, G; Capriglione, S; Luvero, D; Fiore, L; Terranova, C; Montera, R; Panici, Pb
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 1-gen-2015 Angioli, R; Terranova, C; Plotti, F; Cafa, Ev; Gennari, P; Ricciardi, R; Aloisi, A; Miranda, A; Montera, R; Nardone, Cd
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 1-gen-2015 Plotti, F; Scaletta, G; Aloisi, A; Luvero, D; Capriglione, S; Miranda, A; Montera, R; Nardone, Cd; Terranova, C; Angioli, R
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 1-gen-2015 Aloisi, A; Plotti, F; Scaletta, G; Capriglione, S; Laraud, F; Miranda, A; Montera, R; Nardone, Cd; Terranova, C; Angioli, R
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 1-gen-2015 Luvero, D; Plotti, F; Nardone, Cd; Terranova, C; Montera, R; Capriglione, S; Ricciardi, R; Aloisi, A; Miranda, A; Scaletta, G; Lopez, S; Angioli, R
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study 1-gen-2015 Capriglione, S; Plotti, F; Miranda, A; Ricciardi, R; Scaletta, G; Aloisi, A; Guzzo, F; Montera, R; Angioli, R
Ten years of HPV vaccines: State of art and controversies 1-gen-2016 Angioli, R; Lopez, S; Aloisi, A; Terranova, C; De Cicco, C; Scaletta, G; Capriglione, S; Miranda, A; Luvero, D; Ricciardi, R; Montera, R; Plotti, F
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial 1-gen-2016 Capriglione, S; Plotti, F; Montera, R; Luvero, D; Lopez, S; Scaletta, G; Aloisi, A; Serra, Gb; Angioli, R
Learning curves of a resident surgeon performing transobturator tape procedures for stress urinary incontinence 1-gen-2016 Montera, R; Plotti, F; Ricciardi, R; Miranda, A; Venturella, R; Zullo, F; Angioli, R
Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer 1-gen-2016 Plotti, F; Montera, R; Aloisi, A; Scaletta, G; Capriglione, S; Luvero, D; Nardone, Cd; Basile, S; Panici, Pb; Angioli, R
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 1-gen-2017 Scaletta, G; Plotti, F; Luvero, D; Capriglione, S; Montera, R; Miranda, A; Lopez, S; Terranova, C; De Cicco Nardone, C; Angioli, R
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 1-gen-2017 Capriglione, S; Luvero, D; Plotti, F; Terranova, C; Montera, R; Scaletta, G; Schirò, T; Rossini, G; Benedetti Panici, P; Angioli, R
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 1-gen-2017 Plotti, F; Capriglione, S; Terranova, C; Montera, R; Scaletta, G; Lopez, S; Luvero, D; Gianina, A; Aloisi, A; Panici, Pb; Angioli, R
Antiangiogenics and immunotherapies in cervical cancer: an update and future's view 1-gen-2017 Luvero, D; Plotti, F; Lopez, S; Scaletta, G; Capriglione, S; Montera, R; Antonelli, G; Ciuffreda, S; Carassiti, R; Oliveti, A; Angioli, R
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 1-gen-2017 Capriglione, S; Plotti, F; Miranda, A; Lopez, S; Scaletta, G; Moncelli, M; Luvero, D; Nardone, Cd; Terranova, C; Montera, R; Angioli, R
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 1-gen-2017 Plotti, F; Scaletta, G; Capriglione, S; Montera, R; Luvero, D; Lopez, S; Gatti, A; De Cicco Nardone, C; Terranova, C; Angioli, R
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 1-gen-2018 Angioli, R; Plotti, F; Capriglione, S; Terranova, C; DE CICCO, C; Montera, R; Luvero, D
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 1-gen-2018 Plotti, F; Terranova, C; Capriglione, S; Crispino, S; Li Pomi, A; de Cicco Nardone, C; Montera, R; Panici, Pb; Angioli, R; Scaletta, G.
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 1-gen-2018 Plotti, F; Capriglione, S; Scaletta, G; Luvero, D; Lopez, S; Nastro, Ff; Terranova, C; De Cicco Nardone, C; Montera, R; Angioli, R.
Mostrati risultati da 41 a 60 di 80
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile